[HTML][HTML] Incidence and prevalence of multiple sclerosis in Spain: a systematic review

FJG López, A García-Merino, E Alcalde-Cabero… - Neurología (English …, 2024 - Elsevier
Introduction Greater understanding of the prevalence and incidence of multiple sclerosis in
Spain and their temporal trends is necessary to improve the allocation of healthcare …

[HTML][HTML] The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades

L Romero-Pinel, L Bau, E Matas, I León… - Multiple Sclerosis and …, 2022 - Elsevier
Background Patients with relapsing-remitting multiple sclerosis (RRMS) most commonly
experience their first symptoms between 20 and 40 years of age. The objective of this study …

[PDF][PDF] Epidemiología de la esclerosis múltiple en España

N Pérez-Carmona, E Fernández-Jover, AP Sempere - Rev Neurol, 2019 - researchgate.net
Objetivo. Revisar los estudios sobre epidemiología de esclerosis múltiple en España para
verificar si las tendencias mundiales se confirman en nuestro país. Desarrollo. Búsqueda …

[HTML][HTML] Incidencia y prevalencia de la esclerosis múltiple en España. Una revisión sistemática

FJG López, A García-Merino, E Alcalde-Cabero… - Neurología, 2022 - Elsevier
Introducción El conocimiento de la prevalencia y de la incidencia de la esclerosis múltiple
en España y de sus tendencias temporales es necesario para planificar mejor los servicios …

Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data

S Foulon, G Maura, M Dalichampt, F Alla… - Journal of …, 2017 - Springer
Data on the prevalence of multiple sclerosis (MS) in France are scarce. National and
regional updated estimates are needed to better plan health policies. In this nationwide …

Multiple sclerosis epidemiology in Europe

D Bezzini, MA Battaglia - Multiple Sclerosis: Bench to Bedside: Global …, 2017 - Springer
Multiple sclerosis is characterized by a non-homogeneous distribution around the world.
Some authors in past described a latitude gradient, with increasing risk from the equator to …

Risk and outcomes of COVID‐19 in patients with multiple sclerosis

I Moreno‐Torres, V Meca Lallana… - European journal of …, 2021 - Wiley Online Library
Background and purpose Limited information is available on incidence and outcomes of
COVID‐19 in patients with multiple sclerosis (MS). This study investigated the risks of SARS …

Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain

A Sicras-Mainar, E Ruíz-Beato, R Navarro-Artieda… - BMC neurology, 2017 - Springer
Background The impact of comorbidity on multiple sclerosis (MS) is a new area of interest.
Limited data on the risk factors of metabolic syndrome (MetS) is currently available. The aim …

Impact on healthcare resource utilization of multiple sclerosis in Spain

A Sicras-Mainar, E Ruíz-Beato… - BMC Health Services …, 2017 - Springer
Background Multiple sclerosis (MS) is a chronic disease with a high socioeconomic impact.
The aim of this study was to assess healthcare resources utilization and costs in a sample of …

Is the association between health-related quality of life and fatigue mediated by depression in patients with multiple sclerosis? A Spanish cross-sectional study

JJ Fernández-Muñoz, M Cigarán-Méndez… - BMJ open, 2018 - bmjopen.bmj.com
Objectives To determine the mediating effects of depression on health-related quality of life
and fatigue in individuals with multiple sclerosis (MS). Design A cross-sectional study …